An oral formulation for intracellular adhesion molecules-1 antisense oligonucleotides

Transplantation Proceedings

Volumn 33, Issue 7-8, 2001, Pages 3271-

  Stepkowski, S M ^a,c   Chen, W ^a   Geary, R ^b   Wang, M E ^a   Condon, T ^b   Stecker, K ^b   Bennett, C F ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b ISIS PHARMACEUTICALS   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; INTERCELLULAR ADHESION MOLECULE 1; PHOSPHOROTHIOIC ACID DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; ENDOTHELIUM CELL; GRAFT SURVIVAL; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SURVIVAL TIME;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY TRANSPLANTATION; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; RATS; RATS, INBRED ACI; RATS, INBRED LEW; RNA, MESSENGER; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035675955     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(01)02389-2     Document Type: Article

References (3)

1. Stepkowski SM, Wang ME, Condon TP, et al: Transplantation 66:699, 1998
2. Fisher B, Lee S: Surgery 58:904, 1965
3. Levin AA, Monteith DK, Leeds JM, et al: In Crooke ST (ed): Antisense Research Applications. Berlin: Springer-Verlag, 1998, 169